Expertise in
5
conditions

Dr. Kevin N. Foster

District Medical Group Inc
Phoenix, AZ
Expertise in
5
conditions
Specialties:General Surgery
Accepting New Patients
Offers Telehealth
Expertise in
5
conditions
OverviewInsuranceLocationsClinical Research

Overview

Kevin Foster is a General Surgeon in Phoenix, Arizona. Dr. Foster is highly rated in 5 conditions, according to our data. His top areas of expertise are Necrotizing Fasciitis, Compartment Syndrome, Erythema Multiforme, Tissue Biopsy, and Endoscopy. Dr. Foster is currently accepting new patients.

His clinical research consists of co-authoring 64 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
General Surgery
Licenses
Trauma Surgery in AZ
Hospital Affiliations
Valleywise Health Medical Center
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Medica
  •  UnitedHealthcare

Locations

DISTRICT MEDICAL GROUP INC
3141 N 3rd Ave, Phoenix, AZ 85013
602-914-1520
Other Locations
DISTRICT MEDICAL GROUP INC
2601 E Roosevelt St, Phoenix, AZ 85008
602-344-5011

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

A Multicenter, Multinational, Randomized, Controlled, Open Label Study, Performed in Children With Thermal Burns, to Evaluate the Efficacy and Safety of NexoBrid as Compared to Standard of Care (SOC) Treatment
A Multicenter, Multinational, Randomized, Controlled, Open Label Study, Performed in Children With Thermal Burns, to Evaluate the Efficacy and Safety of NexoBrid as Compared to Standard of Care (SOC) Treatment
Enrollment Status: Completed
Publish Date: September 27, 2024
Intervention Type: Drug, Procedure
Study Drug: NexoBrid
Study Phase: Phase 3
Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries
Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries
Enrollment Status: Approved_for_marketing
Publish Date: August 30, 2024
Intervention Type: Drug
A Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of the RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction
A Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of the RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction
Enrollment Status: Completed
Publish Date: July 30, 2024
Intervention Type: Procedure, Device
Study Phase: Not Applicable
CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Enrollment Status: Completed
Publish Date: July 30, 2024
Intervention Type: Device
Study Phase: Not Applicable
Continued Access Protocol: A Prospective, Multicenter, Single-Arm, Observational Study of the Safety and Clinical Performance of RES (Regenerative Epithelial Suspension) Prepared With the ReCell® Device Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Continued Access Protocol: A Prospective, Multicenter, Single-Arm, Observational Study of the Safety and Clinical Performance of RES (Regenerative Epithelial Suspension) Prepared With the ReCell® Device Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Enrollment Status: Completed
Publish Date: July 30, 2024
Intervention Type: Device
A Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RES® (Regenerative Epidermal Suspension) Prepared With the RECELL® Device Compared to Standard of Care Dressings for Treatment of Partial-thickness Burns in Infants, Children and Adolescents (Aged 1-16 Years)
A Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RES® (Regenerative Epidermal Suspension) Prepared With the RECELL® Device Compared to Standard of Care Dressings for Treatment of Partial-thickness Burns in Infants, Children and Adolescents (Aged 1-16 Years)
Enrollment Status: Terminated
Publish Date: July 30, 2024
Intervention Type: Device, Procedure, Combination product
Study Phase: Not Applicable
A Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RES (Regenerative Epidermal Suspension) Prepared With the RECELL® Device Compared to Conventional Care for Healing of Donor Sites in Infants, Children and Adolescents (Aged 1-16 Years)
A Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RES (Regenerative Epidermal Suspension) Prepared With the RECELL® Device Compared to Conventional Care for Healing of Donor Sites in Infants, Children and Adolescents (Aged 1-16 Years)
Enrollment Status: Terminated
Publish Date: July 18, 2024
Intervention Type: Device, Other
Study Phase: Not Applicable
Effects of Enteral Glutamine Supplementation on Mortality and Infectious Morbidity in Severely Burned Patients: a Multi-center Pilot Trial
Effects of Enteral Glutamine Supplementation on Mortality and Infectious Morbidity in Severely Burned Patients: a Multi-center Pilot Trial
Enrollment Status: Unknown
Publish Date: December 30, 2021
Intervention Type: Dietary supplement
Study Phase: Phase 3
Phase 3 Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Reltecimod as Compared to Placebo in Addition to Standard of Care in Patients With Sepsis-associated Acute Kidney Injury (SA-AKI)
Phase 3 Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Reltecimod as Compared to Placebo in Addition to Standard of Care in Patients With Sepsis-associated Acute Kidney Injury (SA-AKI)
Enrollment Status: Terminated
Publish Date: October 12, 2021
Intervention Type: Drug
Study Phase: Phase 3
Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study of AB103 as Compared to Placebo in Patients With Necrotizing Soft Tissue Infections. ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections)
Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study of AB103 as Compared to Placebo in Patients With Necrotizing Soft Tissue Infections. ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections)
Enrollment Status: Completed
Publish Date: October 05, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase III Open-label, Controlled, Randomized, Multicenter Study Evaluating the Efficacy and Safety of StrataGraft Skin Tissue in Promoting Autologous Skin Tissue Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements and for Which Excision and Autografts Are Clinically Indicated
A Phase III Open-label, Controlled, Randomized, Multicenter Study Evaluating the Efficacy and Safety of StrataGraft Skin Tissue in Promoting Autologous Skin Tissue Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements and for Which Excision and Autografts Are Clinically Indicated
Enrollment Status: Completed
Publish Date: July 14, 2021
Intervention Type: Biological, Procedure
Study Phase: Phase 3
A Traditional Feasibility Study to Assess the Safety and Effectiveness of the Biodegradable Temporizing Matrix (BTM) in the Treatment of Deep Burn Skin Injuries.
A Traditional Feasibility Study to Assess the Safety and Effectiveness of the Biodegradable Temporizing Matrix (BTM) in the Treatment of Deep Burn Skin Injuries.
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Device
Study Phase: Not Applicable
Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases
Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases
Enrollment Status: Completed
Publish Date: August 03, 2020
View 12 Less Clinical Trials

64 Total Publications

Cost Analysis of Pure Hypochlorous Acid Preserved Wound Cleanser versus Mafenide for the Irrigation of Burn Wounds.
Cost Analysis of Pure Hypochlorous Acid Preserved Wound Cleanser versus Mafenide for the Irrigation of Burn Wounds.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: July 09, 2024
Similar Doctors
Expertise in
16
conditions
Dr. Sumeet K. Mittal
General Surgery
Expertise in
16
conditions
Dr. Sumeet K. Mittal
General Surgery

Sjhmc Physician Services

500 W Thomas Rd, 680 Dhmg St Joseph's Pelvic Pain And Surg, 
Phoenix, AZ 
 (0.4 mi)
602-406-6017
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Sumeet Mittal is a General Surgeon in Phoenix, Arizona. Dr. Mittal is highly rated in 16 conditions, according to our data. His top areas of expertise are Hiatal Hernia, Gastroesophageal Reflux Disease (GERD), Hernia, Endoscopy, and Gastrostomy. Dr. Mittal is currently accepting new patients.

Expertise in
11
conditions
Dr. Nathaniel J. Soper
General Surgery
Expertise in
11
conditions
Dr. Nathaniel J. Soper
General Surgery

Banner - University Physician Specialists LLC

1441 N 12th St, Fl 2, 
Phoenix, AZ 
 (1.9 mi)
844-242-4664
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nathaniel Soper is a General Surgeon in Phoenix, Arizona. Dr. Soper is highly rated in 11 conditions, according to our data. His top areas of expertise are Hiatal Hernia, Achalasia, Choledocholithiasis, Gallbladder Removal, and Endoscopy. Dr. Soper is currently accepting new patients.

Expertise in
9
conditions
Dr. Barbara A. Pockaj
General Surgery | Surgical Oncology
Expertise in
9
conditions
Dr. Barbara A. Pockaj
General Surgery | Surgical Oncology

Mayo Clinic Arizona

5701 E Mayo Blvd, 
Phoenix, AZ 
 (13.6 mi)
480-342-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Barbara Pockaj is a General Surgeon and a Surgical Oncologist in Phoenix, Arizona. Dr. Pockaj is highly rated in 9 conditions, according to our data. Her top areas of expertise are Breast Cancer, Melanoma, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy. Dr. Pockaj is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile